Why is Samrat Pharma falling/rising?

As of 11-Sep, Samrat Pharmachem Ltd's stock price is currently at 320.95, reflecting an increase of 2.95 (0.93%). Today's price summary indicates that the stock has outperformed its sector by 0.46% and has experienced a trend reversal, gaining after two consecutive days of decline. However, the stock's performance over the past month shows a decline of 4.46%, and it has underperformed significantly over the year with a return of -32.89%. While the company's profits have risen by 32.9%, the stock is trading at a premium compared to its peers, and it has a weak long-term fundamental strength, evidenced by a low ROCE of 3.9 and a CAGR growth in operating profits of only 6.88% over the last five years.
In the broader market context, the stock's short-term return of +0.94% over the past week is slightly below the benchmark Sensex, which has increased by 1.03%. This indicates that while there is some positive movement in the stock price, it is not keeping pace with the overall market. The stock has consistently underperformed against the benchmark over the last three years, which may contribute to cautious investor sentiment. Additionally, a significant drop in delivery volume by 39.62% against the five-day average suggests falling investor participation, which could further impact the stock's price stability in the near term.